BIO-TECHNE Corp — Director's Dealing 2013

Aug 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2013-08-01

Reporting Person: MELSEN GREGORY J (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-08-01	Stock Option (Right to Buy)	$76.02	A	20000	Acquired	2020-07-31	Common Stock (20000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1438	Direct
Common Stock	725	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$39.53	2014-12-16	Common Stock (25000)	25000	Direct
Stock Option (Right to Buy)	$56.83	2014-07-26	Common Stock (783)	783	Direct
Stock Option (Right to Buy)	$79.41	2015-07-24	Common Stock (596)	596	Direct
Stock Option (Right to Buy)	$62.46	2016-07-23	Common Stock (203)	203	Direct
Stock Option (Right to Buy)	$66.25	2017-04-29	Common Stock (30000)	30000	Direct
Stock Option (Right to Buy)	$58.40	2017-07-29	Common Stock (2083)	2083	Direct
Stock Option (Right to Buy)	$76.15	2018-07-27	Common Stock (1803)	1803	Direct
Stock Option (Right to Buy)	$74.05	2019-07-26	Common Stock (1755)	1755	Direct
Stock Option (Right to Buy)	$70.90	2019-11-29	Common Stock (15000)	15000	Direct

Footnotes

F1: Fully exercisable.

F2: Vests 7,500 on each of 4/30/11, 4/30/12, 4/30/13, and 4/30/14.

F3: Vests 5,000 on each of 8/1/14, 8/1/15, 8/1/16, and 8/1/17.